Allomatrine

Allomatrine
Product Name Allomatrine
CAS No.: 641-39-4
Catalog No.: CFN90222
Molecular Formula: C15H24N2O
Molecular Weight: 248.36 g/mol
Purity: >=98%
Type of Compound: Alkaloids
Physical Desc.: Powder
Targets: Bcl-2/Bax | Caspase | Akt | ROS | NF-kB | CDK
Source: The herbs of Sophora alopecuroides L.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $40/20mg
Allomatrine can inhibit proliferation and invasion in vitro of human lung cancer A549 cell line by inducing ROS production,promoting apoptosis, arresting cell cycle, inhibiting ubiquitin proteasome and regulating tumor related gene expression. (+)-Allomatrine and (+)-matrine when given i.c.v. may stimulate the descending dynorphinergic neuron, resulting in the stimulation of KORs in the spinal cord, and this phenomenon in turn produces the antinociception in mice.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Pharmacol Res.2022, 182:106346.
  • J of l. Chroma.&Related Tech2020, 43(11-12):414-423.
  • Eur J Ther.2023, 29(4):900-906.
  • Korean J. Food Sci. & Technol.2022, 54(2):241-246
  • J. Food Composition and Anal.2022, V 109:104482.
  • Pharmaceuticals (Basel).2024, 17(3):341.
  • Molecules.2022, 27(2):451.
  • Foods.2023, 12(6):1227.
  • Industrial Crops and Products2022, 186:115298
  • Journal of Chromatography A2020, 460942
  • Allomatrine

    Catalog No: CFN90222
    CAS No: 641-39-4
    Price: $40/20mg
    Sophoridine

    Catalog No: CFN97172
    CAS No: 6882-68-4
    Price: $30/20mg
    Oxysophoridine

    Catalog No: CFN90290
    CAS No: 54809-74-4
    Price: Inquiry(manager@chemfaces.com)
    Oxysophocarpine

    Catalog No: CFN98321
    CAS No: 26904-64-3
    Price: $60/20mg
    Matrine

    Catalog No: CFN98835
    CAS No: 519-02-8
    Price: $30/20mg
    Lemannine

    Catalog No: CFN92839
    CAS No: 58480-54-9
    Price: Inquiry(manager@chemfaces.com)
    Neosophoramine

    Catalog No: CFN98875
    CAS No: 52932-74-8
    Price: Inquiry(manager@chemfaces.com)
    Sophocarpine

    Catalog No: CFN99182
    CAS No: 145572-44-7
    Price: $30/20mg
    Oxymatrine

    Catalog No: CFN99805
    CAS No: 16837-52-8
    Price: $40/20mg
    (+)-Sophoranol

    Catalog No: CFN92840
    CAS No: 3411-37-8
    Price: Inquiry(manager@chemfaces.com)
    Chinese Pharmaceutical Journal, 2015 , 50 (13) :1111-6.
    Effect and Mechanism of Allomatrine in Proliferation and Invasion in Vitro Inhibition of Human Lung Cancer A549 Cell Line[Reference: WebLink]
    To investigate the effect and mechanism of Allomatrine in proliferation and invasion in vitro inhibition of human lung cancer A549 cell line.
    METHODS AND RESULTS:
    After treatment with Allomatrine, MTS assay was employed to determine the proliferation of cancer cells, flow cytometry to determine the apoptosis rate, cell cycle distribution and intracellular ROS production, transwell assay to determine the cell invasion potential in vitro, adhesion assay to determine the cell adhesion potential in vitro, realtime PCR and Western blotting assay to determine the expression of apoptosis related gene Survivin, Bcl-2 and caspase-3/8, the cell cycle related protein CDK-2, adhesion molecule CD44, matrix metalloproteinases MMP-2/9 and the phosphorylation of AKT, report gene assay to determine the transcription activity of NF-KB and the activity of ubiquitin proteasome. Allomatrine significantly inhibited the proliferation and invasion in vitro of A549 cells, flow cytometry showed that apoptosis rate and ROS production was increased and the cell cycle was halted by G2/M phase, the expression of pro-apoptosis gene caspase-3/8 was upregulated while the anti-apoptosis proteins Survivin and Bcl-2 was downregulated, the expression of CDK-2, CD44 and MMP-2/9 was downregulated, and the phosphorylation of AKT was downregulated, the transcription activity of NF-KB and the activity of ubiquitin proteasome were inhibited after Allomatrine treatment.
    CONCLUSIONS:
    Allomatrine was able to inhibit proliferation and invasion in vitro of human lung cancer A549 cell line by inducing ROS production, promoting apoptosis, arresting cell cycle, inhibiting ubiquitin proteasome and regulating tumor related gene expression.
    Biol Pharm Bull. 2005 May;28(5):845-8.
    Implication of the descending dynorphinergic neuron projecting to the spinal cord in the (+)-matrine- and (+)-allomatrine-induced antinociceptive effects.[Pubmed: 15863891]
    We previously reported that either (+)-matrine (matridin-15-one) or (+)-Allomatrine (the C-6 epimer of matrine)-induced antinociceptive effect was attenuated by s.c. pretreatment with a kappa-opioid receptor (KOR) antagonist nor-binaltorphimine (nor-BNI), indicating the critical role of KORs in antinociceptive effects induced by these alkaloids.
    METHODS AND RESULTS:
    In the present study, we found that i.c.v. administration of either (+)-matrine- or (+)-Allomatrine induced antinociceptive effects in the mouse tail-flick and warm-plate test, whereas these alkaloids when given spinally failed to induce antinociception. In the guanosine-5'-O-(3-[(35)S]thio)trisphosphate ([(35)S]GTPgammaS) binding assay, we demonstrated that neither (+)-matrine nor (+)-Allomatrine produced the stimulation of [(35)S]GTPgammaS binding in the membranes of the spinal cord, indicating that (+)-matrine- and (+)-Allomatrine-induced supraspinal antinociceptive actions was not due to a direct stimulation of KORs by these alkaloids. Therefore, we next investigated the involvement of dynorphin A (1-17) release at the spinal or supraspinal site in (+)-matrine- or (+)-Allomatrine-induced antinociception. The i.c.v. pretreatment with an antiserum against dynorphin A (1-17) could not affect the antinociceptive effect induced by s.c. treatment of (+)-matrine. In contrast, the s.c.-administered (+)-matrine- and (+)-Allomatrine-induced antinociceptive effect was significantly attenuated by i.t. pretreatment of an antiserum against dynorphin A (1-17).
    CONCLUSIONS:
    The present data suggest that either (+)-matrine or (+)-Allomatrine when given i.c.v. may stimulate the descending dynorphinergic neuron, resulting in the stimulation of KORs in the spinal cord, and this phenomenon in turn produces the antinociception in mice.
    Org Lett. 2013 Sep 6;15(17):4596-9.
    Total synthesis of the tetracyclic lupin alkaloid (+)-allomatrine.[Pubmed: 23980915 ]
    (+)-Allomatrine (1) has been synthesized using an imino-aldol reaction and N-acyliminium cyclization as key steps. Strategically, use of the tert-butylsulfinimine derivative of (E)-4-(trimethylsilyl)but-2-enal enabled the staged formation of three C-C bonds, a C-N bond, and the four stereogenic centers within the target.
    2''-O-Galloylquercitrin

    Catalog No: CFN95041
    CAS No: 80229-08-9
    Price: $418/5mg
    Astin C

    Catalog No: CFN95189
    CAS No: 148057-23-2
    Price: $318/10mg
    Nortrachelogenin-5'-C-beta-glucoside

    Catalog No: CFN95251
    CAS No: 858127-39-6
    Price: $318/10mg
    13(S)-Hydroxyoctadeca-9(Z),11(E)-dienoic acid (13-HODE)

    Catalog No: CFN95307
    CAS No: 18104-45-5
    Price: $318/10mg
    Batatasin V

    Catalog No: CFN95320
    CAS No: 65817-45-0
    Price: $318/5mg
    Foliachinenoside C

    Catalog No: CFN95361
    CAS No: 1041180-87-3
    Price: $368/5mg
    Sativanone

    Catalog No: CFN95388
    CAS No: 70561-31-8
    Price: $318/10mg
    New compound 15

    Catalog No: CFN95413
    CAS No: N/A
    Price: $413/5mg
    threo-Guaiacylglycerol-beta-coniferyl aldehyde ether

    Catalog No: CFN95417
    CAS No: 650600-33-2
    Price: $318/5mg
    Cajanine

    Catalog No: CFN95448
    CAS No: 87402-84-4
    Price: $318/5mg